A named U.S. pharmacy fills tizanidine only after a clinician writes it
A checkout that will send tizanidine without a prescription is the listing to leave. The FDA's online-pharmacy update says there are many unsafe online pharmacies that claim to sell prescription drugs at deeply discounted prices, often without requiring a prescription. These internet-based pharmacies often sell unapproved, counterfeit, or otherwise unsafe medicines outside the safeguards followed by licensed pharmacies.
The lawful order names two parties, and they are not the same step. A clinician who can prescribe writes the prescription after evaluating the history and the current medicines. That visit can be in person or by telehealth. The pharmacy that dispenses the medicine is licensed with a state board of pharmacy. In the FDA's account, a pharmacy operating legally always requires a doctor's prescription, lists a physical address and telephone number in the United States, and has a licensed pharmacist who can answer questions. The clinician can send the prescription to a pharmacy the person already uses. A telehealth visit can end at a mail-order pharmacy only when that pharmacy holds its own state license and still requires the prescription. A button that drops tizanidine into a cart does not write the prescription.
A listing meant for animals is the wrong door for an adult spasticity prescription. So is a page that copies the look of a pharmacy and never asks who the prescriber is. What should arrive is the product on the prescription: a Zanaflex capsule printed "2 MG," "4 MG," or "6 MG," or the white 4 mg tablet debossed "A594."
Check that pharmacy on BeSafeRx before any payment
Pay an unfamiliar pharmacy only after the name survives a license check. BeSafeRx is the FDA page for online pharmacy information, including a location tool for a state board of pharmacy license database. Look up the pharmacy that will dispense this prescription. If the online pharmacy is not listed, the FDA says not to use it. A second card number does not repair a name that is absent from that database.
Use the same pause for the warning signs in the FDA online-pharmacy update. Leave the page if it does not require a doctor's prescription, is not licensed in the United States and by your state board of pharmacy, or has no licensed pharmacist to answer questions. Leave it if the price looks too good to be true, or if medicine arrives looking different from a usual pharmacy bottle: broken or damaged packaging, a foreign language, no expiration date, or a date that has passed. A chat reply that the tablet is "the same thing" is not a state license.
Zanaflex capsules and the 4 mg tablet do not swap once food is in the picture
The shared number 4 mg is where a cart goes wrong. Capsules are 2 mg, 4 mg, or 6 mg. The tablet is 4 mg only. Under fasting conditions the capsule and the tablet are bioequivalent. Under fed conditions they are not. Pharmacokinetics also differ between taking a dose with food and taking it without food. Those differences can change tolerability and control of symptoms. Zanaflex may be taken with or without food, and the same relation to meals should hold for each dose, so plasma exposure stays steadier.
Two switches are the ones to refuse at checkout. One is moving a dose from with food to without food, or the reverse. The other is switching dosage forms when the dose is taken with food. If a substitution of form is actually necessary, the pharmacokinetic differences have to be taken into account by the prescriber. They are not a convenience the pharmacy applies so the order can ship today.
The food comparison was a single dose of either two 4 mg tablets or two 4 mg capsules, given fed and fasting, in an open-label crossover study of 96 volunteers, 81 of whom were in the analysis. The figures below are from that capsule-with-food result, measured against the same capsules taken fasting. They were not measured on a 2 mg capsule or a 6 mg capsule, so those percents do not transfer to the other strengths. The label's broader rule still covers every strength: keep food consistent, and do not swap capsule and tablet once a meal is part of the dose.
| Product the prescription names | What the bottle should show | Food |
|---|---|---|
| Zanaflex capsules, 2 mg | Light blue opaque body and light blue opaque cap, with "2 MG" printed on the cap. Each capsule is 2 mg of tizanidine, equivalent to 2.29 mg of tizanidine hydrochloride. | Same relation to meals every dose. The published fed-versus-fasting percents used two 4 mg capsules, not this strength. |
| Zanaflex capsules, 4 mg | White opaque body and blue opaque cap, with "4 MG" printed on the cap. Each capsule is 4 mg of tizanidine, equivalent to 4.58 mg of tizanidine hydrochloride. | With food, two of these capsules showed a mean peak about 20% lower than the same capsules taken fasting, and the extent of absorption about 10% higher. That fed-capsule peak was about 66% of the peak for the tablet given with food, and the amount absorbed was about 80% of the amount absorbed from the tablet given with food. |
| Zanaflex capsules, 6 mg | Blue opaque body with a white stripe and a blue opaque cap, with "6 MG" printed on the capsule. Each capsule is 6 mg of tizanidine, equivalent to 6.87 mg of tizanidine hydrochloride. | Same relation to meals every dose. Do not treat this capsule as a triple of a 2 mg food result. The meal study was not run at 6 mg. |
| Zanaflex tablet, 4 mg | White, uncoated, with a score that divides one side into four and "A594" debossed on the other. Each tablet is 4 mg of tizanidine, equivalent to 4.58 mg of tizanidine hydrochloride. | Fasting, this tablet and the capsules were bioequivalent. With food, they were not. A 4 mg tablet is not a stand-in for a 4 mg capsule when the dose is taken with a meal. The score identifies the tablet. It does not authorize a piece the prescription did not write. |
A listing that says only "tizanidine HCl 4 mg" should be read back to the pharmacist so the 4 mg is the same base the prescription wrote. The brand tablet and the 4 mg capsule are each 4 mg of tizanidine, which equals 4.58 mg of the hydrochloride. If the prescription says capsule and the shipment is a scored tablet, that is a form switch. With a meal in the routine, it is the switch the label says to weigh, not to ignore.
Fluvoxamine and ciprofloxacin are contraindicated
Fluvoxamine and ciprofloxacin stop payment. Concomitant use of Zanaflex with strong CYP1A2 inhibitors is contraindicated, and the label names those two as the examples. The interaction produced a significant drop in blood pressure, more drowsiness, and more psychomotor impairment. Patient counseling is blunt: do not take Zanaflex if you are taking fluvoxamine or ciprofloxacin, because of the risk of a severe drop in blood pressure and sedation.
The label does not offer a smaller tizanidine dose that makes this pair acceptable. Clear fluvoxamine and ciprofloxacin from the plan, and wait until the prescriber confirms the order. If either drug is started after a bottle is already at home, the next tizanidine dose waits for that same confirmation. Tell the prescriber when any medicine is started or stopped. The interaction risk is why that instruction is on the label.
Moderate or weak CYP1A2 inhibitors are a different instruction. The label says to avoid them. The examples it names are zileuton; the antiarrhythmics amiodarone, mexiletine, propafenone, and verapamil; and cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine. It also says there have been no clinical studies of those other inhibitors with tizanidine, so their effect on exposure is not a number you can borrow from the fluvoxamine result. Oral contraceptives are called out again: concomitant use is not recommended. If one of these medicines has to continue and hypotension, a slow pulse, or excessive drowsiness appears, reduce the Zanaflex dose or stop Zanaflex. That fallback belongs to the avoid-list. It is not permission to combine fluvoxamine or ciprofloxacin at a lower dose.
A prior hypersensitivity reaction to tizanidine is its own contraindication. The label describes anaphylaxis, including trouble breathing, hives, and swelling of the throat and tongue. That history ends the order.
Pressure medicines raise the chance of a drop in blood pressure or a slow pulse
Tizanidine is a central alpha-2-adrenergic agonist, and it can produce hypotension. Fainting has been reported in people treated with tizanidine after the drug was on the market. Moving from lying down to a fixed upright position raises the chance of that drop and of orthostatic effects. The label says the risk may be reduced by raising the dose gradually, and by checking for symptoms of low blood pressure before a dose increase.
Blood-pressure medicines add to the drop. Monitor for hypotension when Zanaflex is used in patients receiving concurrent antihypertensive therapy. The combination can have additive hypotensive effects. Bradycardia was also observed, alongside hypotension, in the single-dose study of people with spasticity from multiple sclerosis. If a blood-pressure medicine is already on the list, the bottle waits until the prescriber still wants the combination and someone will actually watch the blood pressure and the pulse. The checkout does not make that decision.
Other alpha-2-adrenergic agonists are a separate line. The label does not recommend Zanaflex with them. That is a different statement from the monitoring instruction for ordinary blood-pressure medicines. Read the list for both.
Spasticity dosing starts at 2 mg and the day stops at 36 mg
Zanaflex is indicated for the treatment of spasticity in adults. The controlled trials were in people with multiple sclerosis or spinal cord injury. The effect is short, and the label says to reserve treatment for the daily activities and times when relief of spasticity is most important. A listing that markets the drug for some other job does not raise the daily ceiling and does not erase the prescription.
How often is written on the starting dose. Take 2 mg by mouth every 6 to 8 hours, as needed, up to three doses in 24 hours. Hours that are not on the prescription are not extra doses. The dose can rise by 2 mg to 4 mg at each dose, every 1 to 4 days, based on response and tolerability. The maximum total daily dosage is 36 mg. Across the three multiple-dose studies, 264 people received tizanidine, and the median dose during the plateau phase ranged from 20 to 28 mg a day. The 36 mg figure is the top of the label, not a quantity to load because shipping is already being paid.
Three limits sit beside each other and answer different questions. Patient counseling says not to take more than prescribed, because of the risk of adverse events at single doses greater than 8 mg or at total daily doses greater than 36 mg. Single doses greater than 16 mg have not been studied. In the single-dose study in multiple sclerosis, 16 mg reduced muscle tone more than 8 mg, and adverse reactions, including hypotension, were more common and more severe than in the 8 mg group. Raising the strength so the order "covers the month" can cross one of those lines even when the daily total still looks legal on a calculator.
How long the effect lasted, in that same single-dose study, is a second clock. Assessments were at 1, 2, 3, and 6 hours. A reduction in muscle tone versus placebo was seen at 1, 2, and 3 hours. The greatest reduction was 1 to 2 hours after the dose. By 6 hours, muscle tone in the 8 mg and 16 mg groups was indistinguishable from placebo. The half-life of tizanidine is about 2.5 hours. That is the time for the parent drug in blood to fall by about half. It does not state that relief lasts 2.5 hours, and it is not the 6-hour point at which the study no longer separated drug from placebo. About 95% of a dose is metabolized. The metabolites are not known to be active, and their half-lives run about 20 to 40 hours, which is a different clock from the parent's 2.5 hours.
In those multiple-dose studies the reactions reported in more than 10% of people on Zanaflex were dry mouth, drowsiness, weakness or fatigue, and dizziness. They appeared dose related. About three-quarters of patients rated them mild to moderate, and about one-quarter rated them severe. That pattern is a reason to keep the titration the prescriber wrote.
Zanaflex contains tizanidine, which is not a controlled substance. The prescription is still required. An overdose can dull alertness from lethargy through coma, slow the heart, drop blood pressure, and depress breathing. Some reported overdoses were fatal. Many of the intentional overdoses involved more than one drug, including other central nervous system depressants. A large count on a page that never asked for a prescription is not a supply plan.
Stopping is a third clock. When the dose has been high for a long time, or when narcotics are also in use, decrease by 2 mg to 4 mg per day to limit withdrawal reactions. Do not stop suddenly. Rebound high blood pressure and a fast pulse can follow an abrupt stop.
Brand, form, and count move the quote
Compare two quotes only when four fields match: the name on the line, Zanaflex or tizanidine; the form, capsule or the 4 mg tablet; the strength, 2 mg, 4 mg, or 6 mg; and the count. The brand package in the prescribing information is a bottle of 150 capsules or 150 tablets. A prescription for 30 units is a different count, and the quote follows the count that was written.
What a person pays also depends on the pharmacy, the insurer, and any discount that pharmacy can show on the receipt. Those amounts differ by plan and by pharmacy. They do not make a capsule taken with food the same order as a tablet taken with food.
A deeply discounted price beside a checkout that skips the prescription is the pattern the FDA describes: unsafe online pharmacies often sell unapproved, counterfeit, or otherwise unsafe medicines, often without requiring a prescription. Leave that page. It does not belong next to a licensed pharmacy's quote for the same prescription.
Hold the bottle until the form, the meals, and the medicine list agree
Release the bottle only when every line below is true. One miss, and the order stops.
- A clinician has written a prescription that names tizanidine or Zanaflex, the form (a 2 mg, 4 mg, or 6 mg capsule, or the 4 mg tablet), and whether each dose is taken with food or without it.
- The pharmacy lists a U.S. address and telephone number, requires that prescription, has a licensed pharmacist who can answer, and is licensed with the state board of pharmacy. The BeSafeRx location tool shows that license. If the pharmacy is not listed, do not pay.
- The cart matches the form. A 4 mg capsule is not the 4 mg tablet. The tablet that arrives is white, quarter-scored, and debossed "A594." Capsules show "2 MG," "4 MG," or "6 MG" on the shell in the table above. A meal in the routine means the form stays the one on the prescription.
- Fluvoxamine and ciprofloxacin are absent. If either is in use, cancel. If either is started later, the next tizanidine dose waits until the prescriber answers.
- Other moderate or weak CYP1A2 inhibitors on the list, including oral contraceptives, have been raised with the prescriber. They are marked avoid, not as a measured substitute for the contraindicated pair.
- Blood-pressure medicines, if already in use, have a plan to watch for hypotension and a slow pulse before the bottle ships. Other alpha-2-adrenergic agonists are not combined with Zanaflex.
- There is no history of hypersensitivity to tizanidine, including trouble breathing, hives, or swelling of the throat or tongue.
- The day's total does not exceed 36 mg. The labeled start is 2 mg every 6 to 8 hours as needed, with at most three doses in 24 hours. Single doses above 16 mg have not been studied. Do not add units so the count looks more economical.
- A long-running higher dose, especially with narcotics, will be lowered by 2 mg to 4 mg per day when it is time to stop, not cut off at once.